Rolf Stahel
Vermogen: 31 297 $ op 31-07-2026
Vermogen: 31 297 $ op 31-07-2026
Rolf Stahel is the founder and the Executive Chairman of Chesyl Pharma Ltd., which was founded in 1994.
He is also the Non-Executive Chairman of Ampha Ltd., starting in 2016.
Mr. Stahel's former positions include being the Chief Executive Officer of Shire Pharmaceuticals, Inc. from 1994 to 2003, the Non-Executive Chairman of EUSA Pharma, Inc., the Chairman of Cosmo Pharmaceuticals SA from 2006 to 2010, the Non-Executive Chairman of PowderMed Ltd. in 2006, the Non-Executive Chairman of Newron Pharmaceuticals SpA from 2012 to 2013, the Deputy Chairman of Cosmo Holding SpA in 2007, the Non-Executive Chairman of Connexios Life Sciences Pvt Ltd. from 2009 to 2016, the Non-Executive Chairman of Ergomed Plc from 2014 to 2017, the Non-Executive Chairman of Biodexa Pharmaceuticals Plc from 2014 to 2022, and the Director-Group Marketing of Wellcome Plc from 1967 to 1994.
Mr. Stahel's education includes an undergraduate degree from Kantons-schule.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
Hargreave Hale AIM VCT
Hargreave Hale AIM VCT Investment ManagersFinance Functions as a private equity fund 0,02% | 05-06-2026 | 76.000 ( 0,02% ) | 31 297 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Ampha Ltd.
Ampha Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Voorzitter | 01-12-2016 |
| Bedrijven | Functie | Einde |
|---|---|---|
Chesyl Pharma Ltd. | Oprichter | 26-08-2024 |
| BIODEXA PHARMACEUTICALS PLC | Voorzitter | 20-06-2022 |
| ERGOMED | Voorzitter | 01-03-2017 |
Connexios Life Sciences Pvt Ltd.
Connexios Life Sciences Pvt Ltd. Pharmaceuticals: GenericHealth Technology Discovers and develops small molecule therapeutics | Voorzitter | 01-01-2016 |
| NEWRON PHARMACEUTICALS S.P.A. | Voorzitter | 18-04-2013 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 13 |
|---|---|
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
Cosmo Pharmaceuticals SA
Cosmo Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company | Health Technology |
Wellcome Plc
Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Operates as a charitable foundation for healthcare | Commercial Services |
PowderMed Ltd.
PowderMed Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products | Health Technology |
Newron Pharmaceuticals SpA
Newron Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and sells novel therapies central & peripheral nervous system | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Cosmo Holding SpA
Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Chesyl Pharma Ltd. | |
Connexios Life Sciences Pvt Ltd.
Connexios Life Sciences Pvt Ltd. Pharmaceuticals: GenericHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Kantons-schule
Kantons-schule Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ergomed Plc
Ergomed Plc BiotechnologyHealth Technology Engages in research and development of drugs for oncology & rare diseases | Health Technology |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Ampha Ltd.
Ampha Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau